Identification of Symptom Clusters and Their Influencing Factors in Subgroups of Chinese Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Limited studies have identified symptom clusters (SCs) and their risk factors and the relationships with inflammatory biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). In this study, we aimed to investigate SCs in patients with AECOPD and explore their...
Gespeichert in:
Veröffentlicht in: | Journal of pain and symptom management 2020-09, Vol.60 (3), p.559-567 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 567 |
---|---|
container_issue | 3 |
container_start_page | 559 |
container_title | Journal of pain and symptom management |
container_volume | 60 |
creator | Yang, Zhenjiao Cui, Miaoling Zhang, Xiaofang Bai, Jing Tang, Lian Tan, Guirong Jiang, Yun |
description | Limited studies have identified symptom clusters (SCs) and their risk factors and the relationships with inflammatory biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
In this study, we aimed to investigate SCs in patients with AECOPD and explore their influencing factors and relationships with inflammatory biomarkers.
Data were collected with sociodemographic and disease information questionnaires, and symptoms were measured with the revised Memorial Symptom Assessment Scale. SCs were extracted through exploratory factor analysis. Logistic regression analysis was conducted to explore the risk factors of SCs.
A total of 151 patients were recruited. Two SCs, namely, emotional and respiratory functional SCs, were identified. Logistic regression analysis showed that individuals with high C-reactive protein level, Charlson Comorbidity Index score, and high modified Medical Research Council Dyspnea Scale score were more likely to belong to the high-severity symptom subgroup than to the low-severity symptom group in the emotional SC. The patients with a low body mass index and without or lax inhaled drug therapy exhibited highly prominent predictors of membership in the high-severity symptom group of the respiratory functional SC.
Symptoms experienced by patients with AECOPD were grouped into specific clusters. Targeted interventions should be performed based on SCs, and influencing factors and biological mechanisms should be considered when providing individualized approaches and interventions. |
doi_str_mv | 10.1016/j.jpainsymman.2020.03.037 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2388820393</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0885392420301901</els_id><sourcerecordid>2448437495</sourcerecordid><originalsourceid>FETCH-LOGICAL-c456t-7d79cba5caf76ff64b4381577301112e7815aa4c51699915c739b18e3042a7723</originalsourceid><addsrcrecordid>eNqNkV2L1DAUhoMo7rj6FyTijTcd89E27eVSd3VgYYVd8TKk6elOSpvUfCzO3_GXmmHWRbwSDoSQ5z3vyXkRekfJlhJaf5y206qMDYdlUXbLCCNbwnOJZ2hDG8GLuqL8OdqQpqkK3rLyDL0KYSKEVLzmL9EZZ0zUlJAN-rUbwEYzGq2icRa7Ed8eljW6BXdzChF8wMoO-G4PxuOdHecEVht7j6-Uji6_GotvU3_vXVrDUd7tjYUA-GtumFsH_N3EPb7QKQK-_Kk0-P7Jqtt7Z43GN32IPuloHrIuzYuzyh_wJxNABXiNXoxqDvDm8TxH364u77ovxfXN5113cV3osqpjIQbR6l5VWo2iHse67Eve0EoITiilDES-KFXqitZt29JKC972tAFOSqaEYPwcfTj1Xb37kSBEuZigYZ6VBZeCZLxpGkZ4yzP6_h90csnbPJ1kZdmUXJRtlan2RGnvQvAwytWbJf9MUiKPQcpJ_hWkPAYpCc8lsvbto0PqFxielH-Sy0B3AiCv5MGAl0HnfWsYjAcd5eDMf9j8Bm-7tv0</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2448437495</pqid></control><display><type>article</type><title>Identification of Symptom Clusters and Their Influencing Factors in Subgroups of Chinese Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Elsevier ScienceDirect Journals</source><creator>Yang, Zhenjiao ; Cui, Miaoling ; Zhang, Xiaofang ; Bai, Jing ; Tang, Lian ; Tan, Guirong ; Jiang, Yun</creator><creatorcontrib>Yang, Zhenjiao ; Cui, Miaoling ; Zhang, Xiaofang ; Bai, Jing ; Tang, Lian ; Tan, Guirong ; Jiang, Yun</creatorcontrib><description>Limited studies have identified symptom clusters (SCs) and their risk factors and the relationships with inflammatory biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
In this study, we aimed to investigate SCs in patients with AECOPD and explore their influencing factors and relationships with inflammatory biomarkers.
Data were collected with sociodemographic and disease information questionnaires, and symptoms were measured with the revised Memorial Symptom Assessment Scale. SCs were extracted through exploratory factor analysis. Logistic regression analysis was conducted to explore the risk factors of SCs.
A total of 151 patients were recruited. Two SCs, namely, emotional and respiratory functional SCs, were identified. Logistic regression analysis showed that individuals with high C-reactive protein level, Charlson Comorbidity Index score, and high modified Medical Research Council Dyspnea Scale score were more likely to belong to the high-severity symptom subgroup than to the low-severity symptom group in the emotional SC. The patients with a low body mass index and without or lax inhaled drug therapy exhibited highly prominent predictors of membership in the high-severity symptom group of the respiratory functional SC.
Symptoms experienced by patients with AECOPD were grouped into specific clusters. Targeted interventions should be performed based on SCs, and influencing factors and biological mechanisms should be considered when providing individualized approaches and interventions.</description><identifier>ISSN: 0885-3924</identifier><identifier>EISSN: 1873-6513</identifier><identifier>DOI: 10.1016/j.jpainsymman.2020.03.037</identifier><identifier>PMID: 32276100</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>AECOPD ; Biological markers ; Biomarkers ; Body mass index ; C-reactive protein ; Chronic obstructive pulmonary disease ; Comorbidity ; Dyspnea ; Exploratory factor analysis ; Intervention ; Medical research ; procalcitonin ; Regression analysis ; Risk factors ; Severity ; Sociodemographics ; symptom cluster ; Symptom severity ; Symptoms</subject><ispartof>Journal of pain and symptom management, 2020-09, Vol.60 (3), p.559-567</ispartof><rights>2020 American Academy of Hospice and Palliative Medicine</rights><rights>Copyright © 2020 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Sep 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c456t-7d79cba5caf76ff64b4381577301112e7815aa4c51699915c739b18e3042a7723</citedby><cites>FETCH-LOGICAL-c456t-7d79cba5caf76ff64b4381577301112e7815aa4c51699915c739b18e3042a7723</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0885392420301901$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,30976,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32276100$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yang, Zhenjiao</creatorcontrib><creatorcontrib>Cui, Miaoling</creatorcontrib><creatorcontrib>Zhang, Xiaofang</creatorcontrib><creatorcontrib>Bai, Jing</creatorcontrib><creatorcontrib>Tang, Lian</creatorcontrib><creatorcontrib>Tan, Guirong</creatorcontrib><creatorcontrib>Jiang, Yun</creatorcontrib><title>Identification of Symptom Clusters and Their Influencing Factors in Subgroups of Chinese Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease</title><title>Journal of pain and symptom management</title><addtitle>J Pain Symptom Manage</addtitle><description>Limited studies have identified symptom clusters (SCs) and their risk factors and the relationships with inflammatory biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
In this study, we aimed to investigate SCs in patients with AECOPD and explore their influencing factors and relationships with inflammatory biomarkers.
Data were collected with sociodemographic and disease information questionnaires, and symptoms were measured with the revised Memorial Symptom Assessment Scale. SCs were extracted through exploratory factor analysis. Logistic regression analysis was conducted to explore the risk factors of SCs.
A total of 151 patients were recruited. Two SCs, namely, emotional and respiratory functional SCs, were identified. Logistic regression analysis showed that individuals with high C-reactive protein level, Charlson Comorbidity Index score, and high modified Medical Research Council Dyspnea Scale score were more likely to belong to the high-severity symptom subgroup than to the low-severity symptom group in the emotional SC. The patients with a low body mass index and without or lax inhaled drug therapy exhibited highly prominent predictors of membership in the high-severity symptom group of the respiratory functional SC.
Symptoms experienced by patients with AECOPD were grouped into specific clusters. Targeted interventions should be performed based on SCs, and influencing factors and biological mechanisms should be considered when providing individualized approaches and interventions.</description><subject>AECOPD</subject><subject>Biological markers</subject><subject>Biomarkers</subject><subject>Body mass index</subject><subject>C-reactive protein</subject><subject>Chronic obstructive pulmonary disease</subject><subject>Comorbidity</subject><subject>Dyspnea</subject><subject>Exploratory factor analysis</subject><subject>Intervention</subject><subject>Medical research</subject><subject>procalcitonin</subject><subject>Regression analysis</subject><subject>Risk factors</subject><subject>Severity</subject><subject>Sociodemographics</subject><subject>symptom cluster</subject><subject>Symptom severity</subject><subject>Symptoms</subject><issn>0885-3924</issn><issn>1873-6513</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNqNkV2L1DAUhoMo7rj6FyTijTcd89E27eVSd3VgYYVd8TKk6elOSpvUfCzO3_GXmmHWRbwSDoSQ5z3vyXkRekfJlhJaf5y206qMDYdlUXbLCCNbwnOJZ2hDG8GLuqL8OdqQpqkK3rLyDL0KYSKEVLzmL9EZZ0zUlJAN-rUbwEYzGq2icRa7Ed8eljW6BXdzChF8wMoO-G4PxuOdHecEVht7j6-Uji6_GotvU3_vXVrDUd7tjYUA-GtumFsH_N3EPb7QKQK-_Kk0-P7Jqtt7Z43GN32IPuloHrIuzYuzyh_wJxNABXiNXoxqDvDm8TxH364u77ovxfXN5113cV3osqpjIQbR6l5VWo2iHse67Eve0EoITiilDES-KFXqitZt29JKC972tAFOSqaEYPwcfTj1Xb37kSBEuZigYZ6VBZeCZLxpGkZ4yzP6_h90csnbPJ1kZdmUXJRtlan2RGnvQvAwytWbJf9MUiKPQcpJ_hWkPAYpCc8lsvbto0PqFxielH-Sy0B3AiCv5MGAl0HnfWsYjAcd5eDMf9j8Bm-7tv0</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Yang, Zhenjiao</creator><creator>Cui, Miaoling</creator><creator>Zhang, Xiaofang</creator><creator>Bai, Jing</creator><creator>Tang, Lian</creator><creator>Tan, Guirong</creator><creator>Jiang, Yun</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>20200901</creationdate><title>Identification of Symptom Clusters and Their Influencing Factors in Subgroups of Chinese Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease</title><author>Yang, Zhenjiao ; Cui, Miaoling ; Zhang, Xiaofang ; Bai, Jing ; Tang, Lian ; Tan, Guirong ; Jiang, Yun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c456t-7d79cba5caf76ff64b4381577301112e7815aa4c51699915c739b18e3042a7723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>AECOPD</topic><topic>Biological markers</topic><topic>Biomarkers</topic><topic>Body mass index</topic><topic>C-reactive protein</topic><topic>Chronic obstructive pulmonary disease</topic><topic>Comorbidity</topic><topic>Dyspnea</topic><topic>Exploratory factor analysis</topic><topic>Intervention</topic><topic>Medical research</topic><topic>procalcitonin</topic><topic>Regression analysis</topic><topic>Risk factors</topic><topic>Severity</topic><topic>Sociodemographics</topic><topic>symptom cluster</topic><topic>Symptom severity</topic><topic>Symptoms</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yang, Zhenjiao</creatorcontrib><creatorcontrib>Cui, Miaoling</creatorcontrib><creatorcontrib>Zhang, Xiaofang</creatorcontrib><creatorcontrib>Bai, Jing</creatorcontrib><creatorcontrib>Tang, Lian</creatorcontrib><creatorcontrib>Tan, Guirong</creatorcontrib><creatorcontrib>Jiang, Yun</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pain and symptom management</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yang, Zhenjiao</au><au>Cui, Miaoling</au><au>Zhang, Xiaofang</au><au>Bai, Jing</au><au>Tang, Lian</au><au>Tan, Guirong</au><au>Jiang, Yun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification of Symptom Clusters and Their Influencing Factors in Subgroups of Chinese Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease</atitle><jtitle>Journal of pain and symptom management</jtitle><addtitle>J Pain Symptom Manage</addtitle><date>2020-09-01</date><risdate>2020</risdate><volume>60</volume><issue>3</issue><spage>559</spage><epage>567</epage><pages>559-567</pages><issn>0885-3924</issn><eissn>1873-6513</eissn><abstract>Limited studies have identified symptom clusters (SCs) and their risk factors and the relationships with inflammatory biomarkers in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD).
In this study, we aimed to investigate SCs in patients with AECOPD and explore their influencing factors and relationships with inflammatory biomarkers.
Data were collected with sociodemographic and disease information questionnaires, and symptoms were measured with the revised Memorial Symptom Assessment Scale. SCs were extracted through exploratory factor analysis. Logistic regression analysis was conducted to explore the risk factors of SCs.
A total of 151 patients were recruited. Two SCs, namely, emotional and respiratory functional SCs, were identified. Logistic regression analysis showed that individuals with high C-reactive protein level, Charlson Comorbidity Index score, and high modified Medical Research Council Dyspnea Scale score were more likely to belong to the high-severity symptom subgroup than to the low-severity symptom group in the emotional SC. The patients with a low body mass index and without or lax inhaled drug therapy exhibited highly prominent predictors of membership in the high-severity symptom group of the respiratory functional SC.
Symptoms experienced by patients with AECOPD were grouped into specific clusters. Targeted interventions should be performed based on SCs, and influencing factors and biological mechanisms should be considered when providing individualized approaches and interventions.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>32276100</pmid><doi>10.1016/j.jpainsymman.2020.03.037</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-3924 |
ispartof | Journal of pain and symptom management, 2020-09, Vol.60 (3), p.559-567 |
issn | 0885-3924 1873-6513 |
language | eng |
recordid | cdi_proquest_miscellaneous_2388820393 |
source | Applied Social Sciences Index & Abstracts (ASSIA); Elsevier ScienceDirect Journals |
subjects | AECOPD Biological markers Biomarkers Body mass index C-reactive protein Chronic obstructive pulmonary disease Comorbidity Dyspnea Exploratory factor analysis Intervention Medical research procalcitonin Regression analysis Risk factors Severity Sociodemographics symptom cluster Symptom severity Symptoms |
title | Identification of Symptom Clusters and Their Influencing Factors in Subgroups of Chinese Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T03%3A51%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification%20of%20Symptom%20Clusters%20and%20Their%20Influencing%20Factors%20in%20Subgroups%20of%20Chinese%20Patients%20With%20Acute%20Exacerbation%20of%20Chronic%20Obstructive%20Pulmonary%20Disease&rft.jtitle=Journal%20of%20pain%20and%20symptom%20management&rft.au=Yang,%20Zhenjiao&rft.date=2020-09-01&rft.volume=60&rft.issue=3&rft.spage=559&rft.epage=567&rft.pages=559-567&rft.issn=0885-3924&rft.eissn=1873-6513&rft_id=info:doi/10.1016/j.jpainsymman.2020.03.037&rft_dat=%3Cproquest_cross%3E2448437495%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2448437495&rft_id=info:pmid/32276100&rft_els_id=S0885392420301901&rfr_iscdi=true |